Brett Sandercock - 20 Aug 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
20 Aug 2021
Net transactions value
-$2,404,542
Form type
4
Filing time
23 Aug 2021, 19:05:27 UTC
Previous filing
20 Aug 2021
Next filing
13 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $299,948 +5,193 +5.8% $57.76 94,979 20 Aug 2021 Direct F1
transaction RMD ResMed Common Stock Options Exercise $320,164 +5,543 +5.8% $57.76 100,522 20 Aug 2021 Direct F1
transaction RMD ResMed Common Stock Sale $3,024,653 -10,736 -11% $281.73 89,786 20 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -5,193 -13% $0.000000 35,543 20 Aug 2021 ResMed Common Stock 5,193 $57.76 Direct F1, F2
transaction RMD ResMed Common Stock Options Options Exercise $0 -5,543 -16% $0.000000 30,000 20 Aug 2021 ResMed Common Stock 5,543 $57.76 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Represents date options first became exercisable. Options vest 1/3 per year.